Product Description
Antifolates are a class of antimetabolite medications that antagonise (that is, block) the actions of folic acid (vitamin B9).[1] Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently, antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as proguanil, pyrimethamine and trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR).
The Drugs For Antifolate Compounds market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Drugs For Antifolate Compounds market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Drugs For Antifolate Compounds Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Drugs For Antifolate Compounds market are:
Baoding Zhongbao Chemical
Mylan Labs
Kissei Pharmaceutical
Bristol-Myers
Genentech
GlaxoSmithKline
IPCA Laboratories
IPCA Laboratories
Cipla
Eli Lilly
Alimta
Most important types of Drugs For Antifolate Compounds products covered in this report are:
Antineoplastic & immunosuppressant
Antineoplastic
Antimalarial
Antiprotozoal
Broad-spectrum antimicrobial
Most widely used downstream fields of Drugs For Antifolate Compounds market covered in this report are:
Methotrexate
Pemetrexed
Proguanil
Pyrimethamine
Trimethoprim
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.